Skip to main content
. 2015 Mar 1;9(3):KC01–KC04. doi: 10.7860/JCDR/2015/11867.5728

[Table/Fig-3]:

Serum lipid and fasting blood glucose levels during the study

Probiotics (n=31) Control (n=33) Difference levels from control
Mean (SD) Mean difference (95% CI) from baseline Mean (SD) Mean difference (95% CI) from baseline Mean difference (95% CI) p-value
Total Cholesterol, mg/dL
Baseline 237.2 (31.7) 231.0 (25.2) 6.2 (-8.0 to 20.9) 0.39
Week 6 212.7 (41.4)* -24.5 (-34.7 to -14.4) † 252.8 (34.2) +21.8 (9.4 to 34.2)† -40.1 (-59.0 to -21.2)* <0.001
HDL-cholesterol, mg/dL
Baseline 56.5 (16.5) 60.7 (18.0) -4.2 (-12.9 to 4.4) 0.33
Week 6 52.0 (10.2)* -4.5 (-9.5 to 0.6) 59.1 (16.0) -1.6 (-8.2 to 4.9) -7.1 (-13.9 to -0.3)* 0.04
LDL-cholesterol, mg/dL
Baseline 158.1 (38.8) 159.4 (26.7) -1.4 (-17.9 to 15.2) 0.87
Week 6 153.9 (44.3)* -4.2 (-16.1 to 7.7) 182.1 (39.3) +22.6 (9.4 to 35.0) † -28.2 (-48.9 to -7.5)* <0.01
Triglycerides, mg/dL
Baseline 175.9 (148.2) 151.0 (52.4) +24.9 (-32.5 to 82.3) 0.38
Week 6 148.0 (97.4) -28.0 (-63.9 to 8.0) 145 (55.6) -5.4 (-30.1 to 19.3) +2.3 (-37.0 to (41.6) 0.91
Fasting blood glucose, mg/dL‡
Baseline 100.0 (91.0-119.0)* 95.0 (90.0-101.0) 0.04
Week 6 97.0 (93.0-108.0) -2.0 (-11.0 to 9.0) § 95.0 (91-101) +2.0 (-5.0 to 6.0) § 0.25

*Significant difference from Control group (p-value<0.05)

†Significant difference from baseline within each group (p-value<0.05)

‡Presented as median (IQR)

§Median difference (95% CI) from baseline